Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration has repeatedly threatened to impose tariffs on medications imported into …
Trump’s tariff threats are spooking pharma. Are MNC stocks the answer?
view original post